Assessing the willingness of parents to pay for reducing postoperative emesis in children.
This study assessed the willingness of parents to pay for a reduction in the postoperative emesis experienced by children. The willingness-to-pay technique was used to value the intangible benefits, such as relief from anxiety and discomfort, resulting from a reduction in postoperative emesis in children; anxiety and discomfort are currently excluded from most cost-effectiveness studies of antiemetic agents. A structured questionnaire was used to interview a representative sample of 162 parents. These were parents, identified by Gallup, whose children had undergone surgery within the previous 2 years and, therefore, were familiar with the postoperative experience. The median willingness to pay for a reduction in postoperative emesis in children was found to be 50 pounds sterling (30% of parents were unwilling to pay more than 5 pounds sterling, while more than 35% of parents were willing to pay 100 pounds sterling or more). Most parents expressed some degree of worry about postoperative nausea and vomiting; 24% were very worried about it. This study found that simple cost-effectiveness studies of antiemetic agents including only direct costs underestimate the true value of the intervention.
Diez
L
L
The Health Economics Department, GlaxoWellcome UK, Middlesex, England.
D000293:Adolescent; D000328:Adult; D000932:Antiemetics / Q000191:economics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010290:Parents; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*
D000932:Antiemetics